Smith V A, Easty D L
Department of Ophthalmology, Bristol Eye Hospital, University of Bristol, UK.
Eur J Ophthalmol. 2000 Jul-Sep;10(3):215-26. doi: 10.1177/112067210001000305.
The activation of matrix metalloproteinase-2 (MMP-2) is postulated to be a crucial pathogenic factor behind progressive and chronic diseases in which basement membranes are disrupted. An ocular example is keratoconus. The purpose of the present enquiry was therefore to investigate and compare the activities of the MMP-2 secreted by keratocytes of normal and keratoconic corneas.
The spectrum of MMP-2 activities secreted by cultures of keratocytes derived from normal and keratoconic corneas was analysed by zymography. Subsequently, selected preparations were assayed for peptidase activity, using Type I, Type III, Type IV and Type V collagen as substrate, under native conditions and after treatment with a variety of putative activating reagents.
Although MMP-2 of Mr 65,000 on SDS gelatin polyacrylamide gels is the major protease secreted by keratocytes of normal corneas, the keratocytes of early-phase keratoconic corneas secrete an additional zymographic activity of Mr 61,000. From their N-terminal amino acid sequences, both these proteins were shown to be conformers of proMMP-2. Treatment with SDS followed by protein fractionation was required to achieve in vitro activation of the MMP-2 secreted by normal corneal keratocytes. Treatment with SDS alone partially activated the enzyme produced by early-phase keratoconic corneal keratocytes. This procedure and autocatalysis, yielded an enzyme of Mr 43,000 that selectively hydrolysed Type IV and denatured Type 1 collagen.
The zymographic gelatinase activities of apparent Mr 65,000 and 61,000 are conformers of corneal proMMP-2. Activated enzyme, of Mr 43,000, is more readily generated from protein preparations of the culture media of early phase keratoconic corneal keratocytes than from protein preparations of the culture media of normal corneal keratocytes.
基质金属蛋白酶-2(MMP-2)的激活被认为是导致基底膜破坏的进行性和慢性疾病背后的关键致病因素。一个眼部例子是圆锥角膜。因此,本研究的目的是调查和比较正常角膜和圆锥角膜的角膜细胞分泌的MMP-2的活性。
通过酶谱分析来自正常角膜和圆锥角膜的角膜细胞培养物分泌的MMP-2活性谱。随后,在天然条件下以及用各种假定的激活试剂处理后,使用I型、III型、IV型和V型胶原作为底物,对选定的制剂进行肽酶活性测定。
虽然在SDS明胶聚丙烯酰胺凝胶上Mr 65,000的MMP-2是正常角膜的角膜细胞分泌的主要蛋白酶,但早期圆锥角膜的角膜细胞分泌一种额外的Mr 61,000的酶谱活性。从它们的N端氨基酸序列来看,这两种蛋白质都被证明是前MMP-2的异构体。正常角膜角膜细胞分泌的MMP-2需要用SDS处理后进行蛋白质分级分离才能在体外激活。单独用SDS处理可部分激活早期圆锥角膜角膜细胞产生的酶。该过程和自催化产生了一种Mr 43,000的酶,该酶选择性地水解IV型和变性I型胶原。
表观Mr 65,000和61,000的酶谱明胶酶活性是角膜前MMP-2的异构体。与正常角膜角膜细胞培养基的蛋白质制剂相比,Mr 43,000的活化酶更容易从早期圆锥角膜角膜细胞培养基的蛋白质制剂中产生。